GATC Health Executives Take the Stage at Biocom California CEO Summits

IRVINE, Calif., November 3, 2026 – GATC Health CBO Tyrone Lam and SVP Mark Flather both spoke as featured panelists across Biocom’s Exclusive CEO Summits in October. At the San Diego event, Lam participated in the panel titled “AI’s Impact on Drug Development, Clinical Operations & Biotech Infrastructure.” During his session, Lam highlighted Operon®, GATC Health’s proprietary, AI platform that drives predictive intelligence and collaborative innovation. At the Bay Area event, Flather spoke on a panel titled “The AI Playbook.” Flather discussed the Derisq® AI Report, explaining how it is powered by Operon and delivered to clients in a report format. 

Mark Flather address the audience on the “The AI Playbook” panel. 

Tyrone Lam speaking at the “AI’s Impact on Drug Development, Clinical Operations & Biotech Infrastructure” session. 

“We deeply value our continued partnership with GATC Health,” said Shaye Exner, Vice President, Events & Sponsorships for Biocom. “GATC’s leaders consistently deliver panel discussions and perspectives that our audiences find informative, engaging, and valuable. We are fortunate to host such sought-after speakers here in California.”